# Young Adults With Early-onset Obesity Treated With Semaglutide

> **NCT05574439** · PHASE4 · COMPLETED · sponsor: **Signe Torekov** · enrollment: 246 (actual)

## Conditions studied

- Obesity, Adolescent

## Interventions

- **BEHAVIORAL:** TCOC treatment
- **DRUG:** Semaglutide 3 mg/ml
- **DRUG:** Placebo (Semaglutide 3 mg/ml)

## Key facts

- **NCT ID:** NCT05574439
- **Lead sponsor:** Signe Torekov
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05574439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05574439, "Young Adults With Early-onset Obesity Treated With Semaglutide". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT05574439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*